The present invention provides a tissue-targeting complex comprising a tissue targeting moiety, an octadentate hydroxypyridinone-containing ligand and the ion of an alpha-emitting thorium radionuclide. The invention additionally provides therapeutic methods employing such complexes, methods of their production and use, and kits and pharmaceutical compositions comprising such complexes.
本发明提供了一种组织靶向复合物,包括一个组织靶向基团、一个含有八齿
羟基吡啶酮的
配体和一个α放射性
钍放射性核素的离子。此外,本发明还提供了使用这种复合物的治疗方法、其生产和使用方法,以及包含这种复合物的试剂盒和药物组合物。